1. The use of hemospray in portal hypertensive bleeding; a case series.
- Author
-
Smith, L.A., Morris, A.J., and Stanley, A.J.
- Subjects
- *
PORTAL hypertension , *HEMORRHAGE , *HEMOSTASIS , *INTESTINAL injuries , *PEPTIC ulcer , *PATIENTS - Abstract
Abstract: Hemospray is a haemostatic agent licensed for endoscopic haemostasis of non-variceal upper gastrointestinal bleeding (NVUGIB) in Europe and Canada. Hemospray has been shown to be safe and effective in achieving haemostasis in bleeding peptic ulcers in a prospective clinical study and several further case series have described the use of hemospray in other non-variceal causes of gastrointestinal bleeding. Portal hypertensive gastropathy and colopathy are common in patients with portal hypertension. As hemospray is an easy to apply, non-contact method, which can cover large areas of mucosa, it may be of benefit in acute non-variceal portal hypertensive bleeding. We present data from the first four consecutive patients presenting to our institution with acute haemorrhage secondary to non-variceal diffuse portal hypertensive bleeding treated with hemospray. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF